Path of differentiation defines human macrophage identity

Insights

Human fetal liver stem cells generate two distinct macrophage types. A novel pathway creates tissue-resident macrophages (TRMs) with self-renewal, offering a target for treating inflammatory diseases like atopic dermatitis.

Area of Science:

  • Immunology
  • Developmental Biology
  • Stem Cell Biology

Background:

  • Macrophages are crucial for immunity, wound healing, and homeostasis.
  • Their functional diversity is linked to developmental origins, but human ontogeny's impact is unclear.
  • Human fetal liver (HFL) hematopoietic stem cells (HSCs) are key to understanding early macrophage development.

Purpose of the Study:

  • To investigate the divergent pathways of macrophage specification from human fetal liver HSCs.
  • To characterize the distinct identities and properties of macrophages derived from these pathways.
  • To explore the therapeutic potential of targeting these pathways in inflammatory conditions.

Main Methods:

  • Utilized human fetal liver HSCs to trace macrophage differentiation pathways.
  • Employed aryl hydrocarbon receptor (AHR) antagonism to modulate macrophage populations.
  • Assessed macrophage properties, including self-renewal and inflammatory responses.
  • Validated findings in preclinical models of atopic dermatitis (AD).

Main Results:

  • Identified two distinct macrophage specification pathways from HFL HSCs: a monocyte-dependent pathway and a fetal-specific expedited differentiation pathway.
  • The fetal pathway generates tissue-resident-like macrophages (TRMs) exhibiting HSC-like self-renewal, regulated by AHR.
  • AHR antagonism promoted TRM expansion and reduced inflammation in atopic dermatitis models.
  • Directly linked differentiation pathways to specific macrophage functional properties.

Conclusions:

  • Human fetal macrophage development involves distinct ontogenetic pathways with differing functional outcomes.
  • AHR-regulated TRMs represent a promising target for managing inflammatory diseases.
  • Targeting macrophage differentiation offers a novel therapeutic strategy for diseases involving macrophage dysfunction.